Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wallwiener

Showing results (521-530 of 789) with videos related to

Pageof 79
Sort By:
JMIR Human Factors|March 5, 2024
Usability and User Experience of an mHealth App for Therapy Support of Patients With Breast Cancer: Mixed Methods Study Using Eye TrackingCarolin Anders, Preetha Moorthy, Laura Svensson, et al.
Journal of the American Heart Association|June 23, 2026
Endothelial Activation and Stress Index in Different Types of Hypertensive Pregnancy DisordersAnna S Scholz, Lena Büchler, Annabel Kussner, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|July 9, 2010
[Sonographic criteria for the differentiation of benign and malignant breast lesions using real-time spatial compound imaging in combination with XRES adaptive image processing]M Hahn, L Roessner, U Krainick-Strobel, et al.
Annals of Surgical Oncology|November 8, 2015
Change of Patient-Reported Aesthetic Outcome Over Time and Identification of Factors Characterizing Poor Aesthetic Outcome After Breast-Conserving Therapy: Long-Term Results of a Prospective Cohort StudyAndré Hennigs, Hannah Biehl, Geraldine Rauch, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancerR Haas, H Schmid, U Hahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE studyPeter Schmid, Michael Untch, Valentin Kossé, et al.
Archives of Gynecology and Obstetrics|October 27, 2015
Efficacy and toxicity profile of pegylated liposomal doxorubicin in patients with advanced ovarian cancerChristine Mayer, Janina Brucker, Florian Schuetz, et al.
BMC Medical Education|February 21, 2024
Exploring the current state of clinical and practical teaching in obstetrics and gynecology in the era of competency-based education: a nationwide survey among German teaching coordinatorsBastian Meyer, Fabian Riedel, Niklas Amann, et al.
Breast Cancer Research and Treatment|April 2, 2011
Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breastMalgorzata Banys, Ines Gruber, Natalia Krawczyk, et al.
Orphanet Journal of Rare Diseases|May 31, 2011
A combination of transcriptome and methylation analyses reveals embryologically-relevant candidate genes in MRKH patientsKatharina Rall, Gianmaria Barresi, Michael Walter, et al.
Pageof 79

Showing results (521-530 of 789) with videos related to

Sort By:
Pageof 79
JMIR Human Factors|March 5, 2024
Usability and User Experience of an mHealth App for Therapy Support of Patients With Breast Cancer: Mixed Methods Study Using Eye TrackingCarolin Anders, Preetha Moorthy, Laura Svensson, et al.
Journal of the American Heart Association|June 23, 2026
Endothelial Activation and Stress Index in Different Types of Hypertensive Pregnancy DisordersAnna S Scholz, Lena Büchler, Annabel Kussner, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|July 9, 2010
[Sonographic criteria for the differentiation of benign and malignant breast lesions using real-time spatial compound imaging in combination with XRES adaptive image processing]M Hahn, L Roessner, U Krainick-Strobel, et al.
Annals of Surgical Oncology|November 8, 2015
Change of Patient-Reported Aesthetic Outcome Over Time and Identification of Factors Characterizing Poor Aesthetic Outcome After Breast-Conserving Therapy: Long-Term Results of a Prospective Cohort StudyAndré Hennigs, Hannah Biehl, Geraldine Rauch, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancerR Haas, H Schmid, U Hahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE studyPeter Schmid, Michael Untch, Valentin Kossé, et al.
Archives of Gynecology and Obstetrics|October 27, 2015
Efficacy and toxicity profile of pegylated liposomal doxorubicin in patients with advanced ovarian cancerChristine Mayer, Janina Brucker, Florian Schuetz, et al.
BMC Medical Education|February 21, 2024
Exploring the current state of clinical and practical teaching in obstetrics and gynecology in the era of competency-based education: a nationwide survey among German teaching coordinatorsBastian Meyer, Fabian Riedel, Niklas Amann, et al.
Breast Cancer Research and Treatment|April 2, 2011
Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breastMalgorzata Banys, Ines Gruber, Natalia Krawczyk, et al.
Orphanet Journal of Rare Diseases|May 31, 2011
A combination of transcriptome and methylation analyses reveals embryologically-relevant candidate genes in MRKH patientsKatharina Rall, Gianmaria Barresi, Michael Walter, et al.
Pageof 79